Every item in the online CME survey must be completed and submitted online by June 30, 2010 in order for continuing education credit to be granted. There is no fee for continuing education credit.
Recording Date
This video was originally recorded on June 31, 2008.
Statement of Need
Community-based primary care providers need the most-up-to date clinical education to effectively diagnose, treat, and medically manage HIV-infected patients.
In addition, new calls by the federal government to make HIV testing routine for all patients between the ages of 13-64 in primary care settings, requires that health care providers are adequately trained on the latest science of HIV testing, referral and initial management, and have access to appropriate resources. The web video series is designed to enhance the ability of this audience to detect HIV infection, deliver routine care to HIV positive individuals and refer to specialists
for the diversity of patients (adolescents, adult women and men, the elderly) cared for in their settings.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Nurse Midwives, Nurses, Dentists, Pharmacists, Mental Health Providers, and other Primary Care Clinicians.
Course Goals and Objectives
This continuing education activity is designed to enhance the ability of primary care providers to detect HIV infection, deliver routine care and to refer to specialists as appropriate for HIV positive women of childbearing-age.
At the conclusion of this activity, the participant should be able to:
1. Describe the epidemiology of HIV disease in women of childbearing age.
2. Discuss the CDC’s Revised Recommendations for HIV Testing and its impact on the primary care setting.
3. Outline new opportunities for HIV testing and prevention in primary care settings.
4. List three unique health issues relevant to women with HIV disease.
5. Describe when to refer patients to Infectious Disease Specialists.
Update about nelfinavir use and pregnancy
As of 3/31/08, all nelfinavir (Viracept) manufactured by Pfizer meets the new limits of EMS established by the FDA for all patient populations, including pregnant women and children. Please see the Dear Healthcare Professional Letter from 5/6/08 online .
Accreditation-expired June 30, 2010
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Albany Medical College and Columbia University. Albany Medical College is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Albany Medical College designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit that is commensurate with the extent of their participation in the activity.
Course Directors
Marshall Glesby, MD, PhD
Medical Director of NY/NJ AETC, Cornell Clinical Trials Unit
Associate Professor of Medicine and Public Health, Weill Cornell Medical College
Douglas Fish, MD
Head, Division of HIV Medicine
Assistant Professor of Medicine
NY/NJ AETC LPS Medical Director
Albany Medical College
NY/NJ AETC Faculty
Judith A. Lightfoot, DO, FACOI
Infectious Disease Specialist, Garden State Infectious Diseases Associates, P.A.
Assistant Clinical Professor of Medicine, UMDNJ-SOM
Planning Committee:
| Sarah J. Walker, MD of Albany Medical Center, HIV Medicine |
Daria Boccher-Lattimore, DrPH of Columbia University, NY/NJ AETC |
| Abigail Gallucci of Albany Medical Center, HIV Medicine |
Melissa Laurie of Columbia University, NY/NJ AETC |
| Jennifer Price of Albany Medical Center, CME |
Kelly Rand, MS of Garden State Infectious Disease Associate |
Disclosures
Albany Medical College endorses the standards of the Accreditation Council for Continuing Medical Education (ACCME) and the guidelines of the Association of American Medical Colleges (AAMC) that the sponsors of continuing medical education activities, speakers, and planning committee members of these activities disclose significant relationships with commercial companies. Significant relationships include receiving from a commercial company research grants, consultancies, honoraria and travel, or other benefits or have a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Relationships exist with the following companies/organizations:
PLANNING COMMITTEE |
COMPANY & RELATIONSHIP |
| Douglas G. Fish, MD |
Speaker’s Bureau: Merck & Boehringer Ingelheim
Consultant:Merck |
| Abigail Gallucci |
Speaker’s Bureau: Gilead Sciences, Inc |
The following Faculty or Planning Committee Members have no financial relationships to disclose: Marshall Glesby, MD, PhD, Judith Lightfoot, DO, FACCOI, Jennifer Price, Sarah Walker, Kelly Rand, Melissa Laurie and Daria Boccher-Lattimore, DrPH
Acknowledgements
This program is a collaborative initiative among the Division of HIV Medicine at Albany Medical College and Columbia University College of Physicians and Surgeons for the NY/NJ AIDS Education and Training Center.
Thank you to Abbott Laboratories, Inc. for providing an unrestricted educational grant.
Watch the Video
If you have problems viewing the video
Make sure you have the latest version of adobe flash player installed on your computer.
If the problem persists, please let us know.
If you have any questions, please contact
NY/NJ AIDS Education & Training Center
HIV Center, Department of Psychiatry
Columbia University College of Physicians and Surgeons
100 Haven Ave #31G
New York, NY 10032
nynjaetc@columbia.edu
212-304-5530
Copyright 2009, the New York/New Jersey AIDS Education and Training Center unless otherwise noted. All rights reserved.
Email nynjaetc@columbia.edu with questions, comments, or problems.
See disclaimer for usage guidelines. |
